Literature DB >> 15100259

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

Song Guo Zheng1, Ju Hua Wang, J Dixon Gray, Harold Soucier, David A Horwitz.   

Abstract

Thymus-derived, natural CD4(+)CD25(+) regulatory T cells can educate peripheral CD4(+)CD25(-) cells to develop suppressive activity by poorly understood mechanisms. TGF-beta has IL-2-dependent costimulatory effects on alloactivated naive, human CD4(+) T cells and induces them ex vivo to become potent contact-dependent, cytokine-independent suppressor cells. In this study, we report that CD4(+)CD25(+) cells are the targets of the costimulatory effects of IL-2 and TGF-beta. These cells do not divide, but, instead, greatly increase the numbers of CD4(+)CD25(-) cells that become CD25(+) cytokine-independent suppressor cells. These CD4(+)CD25(+) regulatory cells, in turn, induce other alloactivated CD4(+)CD25(-) cells to become potent suppressor cells by mechanisms that, surprisingly, require both cell contact and TGF-beta and IL-10. The suppressive effects of these secondary CD4(+)CD25(+) cells depend upon TGF-beta and IL-10. Moreover, both the naive CD4(+) cells induced by IL-2 and TGF-beta to become suppressor cells, and the subsequent CD4(+)CD25(-) cells educated by them to become suppressors express FoxP3. We suggest that the long-term effects of adoptively transferred natural-like CD4(+)CD25(+) regulatory cells induced ex vivo are due to their ability to generate new cytokine-producing CD4(+) regulatory T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100259     DOI: 10.4049/jimmunol.172.9.5213

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  215 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

Review 2.  Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

Authors:  Qin Lan; Huimin Fan; Valerie Quesniaux; Bernhard Ryffel; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2011-11-22       Impact factor: 6.216

3.  Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.

Authors:  Qin Lan; Xiaohui Zhou; Huimin Fan; Maogen Chen; Julie Wang; Bernhard Ryffel; David Brand; Rajalakshmy Ramalingam; Pawel R Kiela; David A Horwitz; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2012-07-06       Impact factor: 6.216

4.  Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.

Authors:  Xiaohui Zhou; Julie Wang; Wei Shi; David D Brand; Zhongmin Liu; Huimin Fan; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2010-04-29       Impact factor: 6.216

5.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Authors:  Weiming Ouyang; Omar Beckett; Qian Ma; Ji-hye Paik; Ronald A DePinho; Ming O Li
Journal:  Nat Immunol       Date:  2010-05-13       Impact factor: 25.606

Review 6.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injury.

Authors:  Ling Lu; Min Feng; Jia Gu; Zanxian Xia; Hongjun Zhang; Sujun Zheng; Zhongping Duan; Richard Hu; Julie Wang; Wei Shi; Cheng Ji; Yi Shen; Guihua Chen; Song Guo Zheng; Yuan-Ping Han
Journal:  J Mol Cell Biol       Date:  2013-12       Impact factor: 6.216

8.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

Review 9.  The guiding role of bone metabolism test in osteoporosis treatment.

Authors:  Wei Zhang; Guo-Ji Yang; Shi-Xian Wu; Dong-Qing Li; Ying-Bo Xu; Cheng-Hong Ma; Jun-Ling Wang; Wei-Wen Chen
Journal:  Am J Clin Exp Immunol       Date:  2018-04-05

Review 10.  Retinoic acid in the immune system.

Authors:  Karina Pino-Lagos; Micah J Benson; Randolph J Noelle
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.